3653 results for «358»
3653 results
TAVI with a new generation of valve and difficult arterial access - LIVE case
07 Dec 2023 – From GulfPCR-GIM 2023
An 84-year-old woman with type 2 diabetes, anaemia (Hgb: 9 g/dl), morbid obesity and limited mobility, and mild LV function impairment (50%), presented an acute heart failure on severe aortic valve stenosis.
The operators decided to implant an Evolut FX by femoral access with secondary access in...
How should I treat my female patients?
07 Dec 2023 – From GulfPCR-GIM 2023
This 100% all-female session, in every aspect, highlights the fact that female patients have a higher prevalence of SCAD and MINOCA, focuses on the advances in everyday technologies such as intracoronary imaging and intracoronary functional assessment that facilitate the establishment of a definitive diagnosis in many...
Challenging structural interventions: part 1
06 Dec 2023 – From GulfPCR-GIM 2023
In these slides, explore a selection of cases focusing on challenging structural interventions, with a case of complex bicuspid aortic valve, and a special focus on TAVI dysfunction.
Five most impactful trials in 2023
02 Jan 2024 – From GulfPCR-GIM 2023
Find out how, based on an initial clinical situation, the scientific evidence gathered between January and December on the key subjects selected for 2023, focusing on coronary issues, might have had an impact on daily practice, or is encouraging changes in practice, from MVD in ACS...
Cracking new horizons across all calcium morphologies
07 Dec 2023 – From GulfPCR-GIM 2023
Watch this session to learn all about the intravascular lithotripsy (IVL) mechanism for treating calcified lesions. Discover practical advice and techniques for implementing IVL in challenging calcified lesions and the safe utilization of IVL in left main bifurcations.
Left main stenting: one vs. two stent strategy
06 Dec 2023 – From GulfPCR-GIM 2023
In these selected clinical cases, discover strategies on whether to choose one or two stents in the case of left main disease. Explore the use of effective imaging, IABP, and other mechanical support devices.
Ultra-low contrast techniques in complex and high-risk coronary interventions
07 Dec 2023 – From GulfPCR-GIM 2023
Explore this session to gain insights into reducing operator reliance on contrast in PCI for enhanced safety and quality, particularly in complex scenarios. Discover essential tips, tricks, and specialized tools tailored for ultra-low-contrast PCI. Additionally, immerse yourself in a practical, step-by-step example through a recorded ultra-low-contrast...
Complex PCI in high bleeding risk patients, the way forward!
07 Dec 2023 – From GulfPCR-GIM 2023
Consult this session for insights on customizing PCI strategies for high-bleeding-risk patients, and selecting Drug-Eluting Stents in complex PCI. Additionally, examine the outcomes of the Ultimaster DES in high-bleeding-risk trials, particularly in the context of short Dual Antiplatelet Therapy.
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
World Heart Day 2023: Reducing the burden of cardiovascular disease globally: beyond stents and balloons!
29 Sep 2023
Global burden of Cardiovascular Disease
Cardiovascular disease (CVD) remains the lead cause of mortality for men and women globally. Our world population in 2023 is 8 billion! Of these, around 620 million people are living with heart and circulatory diseases across the world. Each year around 60...
Author
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
The Lancet Commission to reduce global burden of cardiovascular disease in women by 2030
29 Aug 2021
Vijay Kunadian summarizes the key points of the LBT session of the ESC congress 2021 held on Sunday, 29 August focusing on the Lancet Commission to reduce the global burden of heart disease in women by 2030.
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
